Skip Nav

HIV/AIDS Clinical Trials

Home > Clinical Trials > Search Results
Español Text Size

Recruiting Status Legend

Studies Seeking Participants

Recruiting
Not yet recruiting
Available for expanded access

Studies Not Seeking Participants

Active, not recruiting
Completed
Terminated
Suspended
Withdrawn
Enrolling by invitation
Temporarily not available for expanded access
No longer available for expanded access
Approved for marketing

Clinical Trial Search Results

14 studies were found about Trials by Study Type, Expanded Access

HIV-discordant Couple Intrauterine Insemination

Condition: Infertility; HIV Infections

NCT ID: NCT00975546

Available

TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.

Condition: HIV Infections

NCT ID: NCT00245739

Approved for marketing

Emergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment

Condition: HIV Infections

NCT ID: NCT00062660

Available

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Condition: HIV Infections

NCT ID: NCT00933205

No longer available

Fosamprenavir Expanded Access

Condition: HIV Infection

NCT ID: NCT00240552

No longer available

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.

Condition: HIV-1

NCT ID: NCT00354627

Approved for marketing

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT00992654

No longer available

Atazanavir for HIV Infected Individuals: An Early Access Program

Condition: HIV Infections

NCT ID: NCT00046345

No longer available

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

Condition: HIV Infection

NCT ID: NCT00162227

Available

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada

Condition: HIV Infection

NCT ID: NCT00162188

Available

Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00377065

Approved for marketing

Dolutegravir Expanded Access Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01536873

Available

Tipranavir Expanded Access Program (EAP)

Condition: HIV Infections

NCT ID: NCT00097799

No longer available

A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

Condition: HIV

NCT ID: NCT00801515

No longer available